BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17192050)

  • 21. Identification of Circulating MiR-25 as a Potential Biomarker for Pancreatic Cancer Diagnosis.
    Deng T; Yuan Y; Zhang C; Zhang C; Yao W; Wang C; Liu R; Ba Y
    Cell Physiol Biochem; 2016; 39(5):1716-1722. PubMed ID: 27639768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry.
    Koopmann J; Zhang Z; White N; Rosenzweig J; Fedarko N; Jagannath S; Canto MI; Yeo CJ; Chan DW; Goggins M
    Clin Cancer Res; 2004 Feb; 10(3):860-8. PubMed ID: 14871961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum heat shock protein 27 is increased in chronic pancreatitis and pancreatic carcinoma.
    Liao WC; Wu MS; Wang HP; Tien YW; Lin JT
    Pancreas; 2009 May; 38(4):422-6. PubMed ID: 19214136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis.
    Chang MC; Chang YT; Su TC; Yang WS; Chen CL; Tien YW; Liang PC; Wei SC; Wong JM
    Pancreas; 2007 Jul; 35(1):16-21. PubMed ID: 17575540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens.
    Haab BB; Huang Y; Balasenthil S; Partyka K; Tang H; Anderson M; Allen P; Sasson A; Zeh H; Kaul K; Kletter D; Ge S; Bern M; Kwon R; Blasutig I; Srivastava S; Frazier ML; Sen S; Hollingsworth MA; Rinaudo JA; Killary AM; Brand RE
    PLoS One; 2015; 10(10):e0139049. PubMed ID: 26431551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SELDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of a boosting decision tree model for diagnosis of pancreatic cancer.
    Qian JY; Mou SH; Liu CB
    Asian Pac J Cancer Prev; 2012; 13(5):1911-5. PubMed ID: 22901146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
    Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
    J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The assessment of serum concentration of adiponectin, leptin and serum carbohydrate antigen-19.9 in patients with pancreatic cancer and chronic pancreatitis.
    Dranka-Bojarowska D; Lekstan A; Olakowski M; Jablonska B; Lewinski A; Musialski P; Sobczyk W; Kapalka A; Lampe P
    J Physiol Pharmacol; 2015 Oct; 66(5):653-63. PubMed ID: 26579571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of N-glycan markers that improve the performance of CA19-9 in pancreatic cancer.
    Zhao YP; Zhou PT; Ji WP; Wang H; Fang M; Wang MM; Yin YP; Jin G; Gao CF
    Clin Exp Med; 2017 Feb; 17(1):9-18. PubMed ID: 26714469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of pancreatic adenocarcinoma using protein chip technology.
    Liu D; Cao L; Yu J; Que R; Jiang W; Zhou Y; Zhu L
    Pancreatology; 2009; 9(1-2):127-35. PubMed ID: 19077463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer.
    Ventrucci M; Cipolla A; Racchini C; Casadei R; Simoni P; Gullo L
    Dig Dis Sci; 2004 Aug; 49(7-8):1149-55. PubMed ID: 15387337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum HSP70: a novel biomarker for early detection of pancreatic cancer.
    Dutta SK; Girotra M; Singla M; Dutta A; Otis Stephen F; Nair PP; Merchant NB
    Pancreas; 2012 May; 41(4):530-4. PubMed ID: 22158074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical value of serum neopterin, tissue polypeptide-specific antigen and CA19-9 levels in differential diagnosis between pancreatic cancer and chronic pancreatitis.
    Talar-Wojnarowska R; Gasiorowska A; Olakowski M; Lekstan A; Lampe P; Malecka-Panas E
    Pancreatology; 2010; 10(6):689-94. PubMed ID: 21242708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels.
    Chang MC; Liang PC; Jan S; Yang CY; Tien YW; Wei SC; Wong JM; Chang YT
    Pancreatology; 2014; 14(5):366-72. PubMed ID: 25278306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Small Proteins and Peptides in the Differentiation of Patients with Intraductal Mucinous Neoplasms of the Pancreas, Chronic Pancreatitis and Pancreatic Adenocarcinoma.
    Fania C; Pezzilli R; Melzi d'Eril G; Gelfi C; Barassi A
    Dig Dis Sci; 2018 Apr; 63(4):920-933. PubMed ID: 29417328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer.
    Kuhlmann KF; van Till JW; Boermeester MA; de Reuver PR; Tzvetanova ID; Offerhaus GJ; Ten Kate FJ; Busch OR; van Gulik TM; Gouma DJ; Crawford HC
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):886-91. PubMed ID: 17507610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of serum parameters panels for the early detection of pancreatic cancer.
    Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
    Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Mayerle J; Kalthoff H; Reszka R; Kamlage B; Peter E; Schniewind B; González Maldonado S; Pilarsky C; Heidecke CD; Schatz P; Distler M; Scheiber JA; Mahajan UM; Weiss FU; Grützmann R; Lerch MM
    Gut; 2018 Jan; 67(1):128-137. PubMed ID: 28108468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Differential diagnosis of pancreatic head cancer].
    Kubyshkin VA; Vishnevskiĭ VA; Aĭrapetian AT; Karmazanovskiĭ GG; Kuntsevich GI; Starkov IuG
    Khirurgiia (Mosk); 2000; (11):19-23. PubMed ID: 11220911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis.
    Rychlíková J; Vecka M; Jáchymová M; Macášek J; Hrabák P; Zeman M; Vávrová L; Řoupal J; Krechler T; Ák A
    Cancer Biomark; 2016 Jun; 17(1):55-65. PubMed ID: 27314293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.